Liquidia Corp License Agreements
5 Contracts & Agreements
- First Amendment to the License Agreement, dated as of October 2, 2024, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc (Filed With SEC on November 13, 2024)
- Device License Agreement, dated as of October 2, 2024, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc (Filed With SEC on November 13, 2024)
- License Agreement, dated as of June 28, 2023, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc (Filed With SEC on March 13, 2024)
- License Agreement, dated as of June 28, 2023, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc (Filed With SEC on August 10, 2023)
- Research License Agreement, dated as of March 31, 2023, by and between Liquidia Technologies, Inc. and Glaxo Group Limited (Filed With SEC on May 8, 2023)
